Red cell transfusion therapy in the critical care setting.

Area of Science:

• Critical Care Medicine
• Hematology

Background:

• Red blood cell transfusion frequency in ICUs ranges from 0.2 to 0.4 units/patient/day.
• Transfusion aims to restore oxygen-carrying capacity and prevent tissue hypoxia.
• Phlebotomy is a significant source of blood loss in critically ill patients.

Purpose of the Study:

• To evaluate the current practices and rationale for red blood cell transfusion in intensive care units.
• To determine optimal transfusion triggers based on individual patient status rather than fixed thresholds.
• To discuss the potential benefits and risks of red blood cell transfusion in critically ill patients.

Main Methods:

• Review of published reports and clinical experience regarding red cell transfusion in ICUs.
• Analysis of adaptive mechanisms to anemia, including increased cardiac output.
• Discussion of the concept of supply dependency of oxygen consumption in critically ill patients.

Main Results:

• No basis exists for a fixed transfusion trigger, such as hemoglobin < 100 g/L.
• Individualized transfusion triggers, considering patient comorbidities and disease severity, are adequate.
• Maximizing oxygen delivery in critically ill patients has shown no proven benefit in recent studies.

Conclusions:

• The decision to transfuse red blood cells must be individualized, considering patient status, risks, and benefits.
• Blood-sparing techniques may reduce future transfusion rates in ICUs.
• Current evidence does not support fixed transfusion thresholds for critically ill patients.